|
|
Volumn 23, Issue 9, 2005, Pages 1054-1058
|
|
Flexibility - The guiding principle for antibody manufacturing
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOTECHNOLOGY;
STRATEGIC PLANNING;
ANTIBODY MANUFACTURING;
BIOTECH INDUSTRY;
MONOCLONAL ANTIBODIES;
MONOCLONAL ANTIBODY;
RECOMBINANT ANTIBODY;
AFFINITY CHROMATOGRAPHY;
BIOASSAY;
BIOREACTOR;
BIOTECHNOLOGY;
CHEMICAL WASTE;
CHROMATOGRAPHY;
CROSSFLOW FILTRATION;
DRUG MANUFACTURE;
FILTRATION;
FINANCIAL MANAGEMENT;
GLYCOSYLATION;
ION EXCHANGE CHROMATOGRAPHY;
LEASING;
MASS SPECTROMETRY;
NUCLEAR MAGNETIC RESONANCE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PURIFICATION;
PURIFICATION;
REVIEW;
VALIDATION PROCESS;
WASTE DISPOSAL;
X RAY CRYSTALLOGRAPHY;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BIOPHARMACEUTICS;
BIOTECHNOLOGY;
CHEMISTRY, PHARMACEUTICAL;
DRUG INDUSTRY;
HUMANS;
MICE;
RESEARCH SUPPORT;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 27144553142
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0905-1054 Document Type: Review |
|
Times cited : (63)
|
|
References (0)
|
